Octapharma Trial On Intravenous Immunoglobulin (IVIG) In Alzheimer's Disease At ICAD 2010 Congress
Links shared publicly online about this topic.
- 1,224total visits
Octapharma Trial On Intravenous Immunoglobulin (IVIG) In Alzheimer's Disease At ICAD 2010 Congress
The on-going phase II trial on Octapharma's 10% intravenous immunoglobulin octagam®10% will be a topic at the up-coming International Conference on Alzheimer's Disease (ICAD 2010) to take plac
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Disease and Condition, disease
Most Recently Shared on April 21, 2010 at 12:16 pm By:
Octapharma Trial On Intravenous Immunoglobulin (IVIG) In Alzheimer's Disease At ICAD 2010 Congress http://mnt.to/3BvZ #alzheimers
Advertisement
